Calprotectin: What It Is and How to Lower It Naturally

A complete, research-backed guide to understanding your calprotectin levels — and the natural strategies proven to reduce intestinal inflammation.

Introduction: What is Calprotectin?

If your doctor has ordered a stool test and mentioned the word “calprotectin,” you may be wondering what exactly this protein is and what elevated levels really mean for your health. You’re not alone — calprotectin has become one of the most important biomarkers in modern gastroenterology, yet most patients have never heard of it before seeing it on a lab report.

Calprotectin is a calcium- and zinc-binding protein predominantly found inside neutrophils — the white blood cells that rush to sites of infection or injury as your body’s first line of immune defence. When the intestinal lining becomes inflamed, neutrophils flood into the gut wall and release calprotectin in large quantities. This protein then passes through the intestine and can be measured in a stool (fecal) sample, giving clinicians a remarkably accurate window into what is happening inside your gut — without the need for an immediate invasive endoscopy.

The protein was first described by researchers in the early 1980s, but it was a landmark paper by Fagerhol and colleagues in the 1990s that brought fecal calprotectin testing into mainstream clinical use. Since then, hundreds of peer-reviewed studies indexed on PubMed have confirmed its extraordinary utility as a biomarker of intestinal inflammation.

Key insight: Calprotectin accounts for up to 60% of the total protein content inside a neutrophil’s cytoplasm. This means that whenever the gut is inflamed and neutrophils are recruited and dying at the mucosal surface, calprotectin floods the intestinal lumen in measurable amounts. It is, in essence, a direct footprint of active gut inflammation.

How Calprotectin Works in the Body

To understand why calprotectin is such a valuable clinical marker, it helps to understand its role in the immune system at a molecular level.

At the intracellular level (inside the cell), calprotectin exerts regulatory functions through interactions with zinc-dependent metalloproteinases (proteins) and by activating the synthesis of pro-inflammatory molecules called cytokines. It also modulates cell-signalling pathways associated with innate immunity, promotes leukocyte recruitment, and facilitates the transport of arachidonic acid — a precursor of pro-inflammatory compounds — to sites of tissue inflammation.

Once released into the extracellular environment (outside the cell), calprotectin performs a further crucial role: direct antimicrobial defence. It does this through the chelation and sequestration of zinc and manganese ions. By stripping bacteria of these essential micronutrients, calprotectin literally starves pathogens of the minerals they need to grow and divide. This makes it a key component of a process called “nutritional immunity.”

Calprotectin also contributes to the inflammatory cascade through neutrophil chemotaxis — it acts as a chemical signal that attracts even more neutrophils to the site of inflammation, amplifying the immune response. This self-amplifying loop is one reason why chronic gut inflammation, as seen in conditions like Crohn’s disease and ulcerative colitis, is so difficult to extinguish once it becomes established.

Fecal calprotectin is particularly useful because it is remarkably stable at room temperature for up to seven days, making it practical for home stool collection. It also does not degrade significantly during intestinal transit — meaning that what is secreted into the gut wall is accurately reflected in the stool sample.

Normal Ranges and What the Numbers Mean

Understanding your calprotectin result requires knowing what the numbers actually represent. Laboratories typically measure calprotectin in micrograms per gram (µg/g) of stool, though some labs may express this as mg/kg, which is numerically equivalent.

Calprotectin Reference Ranges:

Important note on age-related variation: Reference ranges differ significantly between adults and children. Infants and young children — particularly under two years of age — naturally have much higher calprotectin levels, sometimes exceeding 500 µg/g, without any pathological cause. Always interpret results with guidance from a qualified clinician familiar with age-appropriate thresholds.

From a clinical standpoint, a threshold of 200 µg/g is widely used to differentiate patients with likely active mucosal disease from those in remission. A result persistently above 200 µg/g in an IBD patient, even when they feel well clinically, is a warning sign of smouldering mucosal inflammation that substantially elevates relapse risk.

How is the test performed?

Fecal calprotectin is measured from a small stool sample, typically collected at home using a sample pot provided by your GP or gastroenterology clinic. Most guidelines recommend collecting from the first bowel movement of the day for the most representative result. The sample is then sent to a laboratory for enzyme-linked immunosorbent assay (ELISA) analysis. Results are usually available within a few days. Home testing kits are also commercially available, though laboratory testing remains the gold standard for clinical decisions.

What Causes High Calprotectin?

While many people immediately associate high calprotectin with IBD, it is important to understand that calprotectin is a marker of intestinal inflammation, not a diagnosis in itself. Many different conditions and triggers can cause neutrophil recruitment into the gut wall, leading to elevated levels. Think of calprotectin as a fire alarm — it tells you there is fire, but not necessarily where or why.

Common causes of elevated fecal calprotectin include:

Inflammatory Bowel Disease (IBD): The most clinically significant cause in adults. Both Crohn’s disease and ulcerative colitis drive substantial neutrophil infiltration of the intestinal mucosa, producing consistently elevated calprotectin levels that track closely with disease activity and endoscopic findings.

Gastrointestinal infections: Bacterial, viral, and parasitic infections of the gut cause acute neutrophil recruitment and can transiently elevate calprotectin levels. This is particularly relevant in children, where infectious gastroenteritis is common and must be distinguished from IBD.

Non-steroidal anti-inflammatory drugs (NSAIDs): Regular use of ibuprofen, naproxen, and related medications is well documented to cause intestinal mucosal damage and elevated calprotectin, even in the absence of IBD.

Colorectal cancer and polyps: Neoplastic processes in the colon trigger a local inflammatory response, and elevated calprotectin has been studied as a screening signal for colorectal malignancy, though its specificity for this indication remains lower than for IBD.

Coeliac disease: Active untreated coeliac disease causes small intestinal inflammation measurable by calprotectin. Notably, levels typically normalise on a strict gluten-free diet, making calprotectin a useful monitoring tool in this condition.

Gut microbiome dysbiosis: An imbalance in the gut bacterial community can trigger low-grade mucosal immune activation even without overt disease, producing mildly elevated calprotectin in otherwise healthy individuals.

High-intensity exercise: Strenuous, prolonged exercise — particularly distance running — is associated with transient intestinal permeability and mild calprotectin elevation due to mechanical stress and reduced gut blood flow during exertion.

Clinical pearl: Proton pump inhibitors (PPIs) such as omeprazole — among the most commonly prescribed drugs in the UK — have been associated with mildly elevated calprotectin levels in some studies. Always disclose all medications to your doctor when interpreting results.

Conditions Linked to Elevated Calprotectin

Beyond the gut itself, research published in PubMed-indexed journals has revealed that calprotectin elevation extends across a surprising range of inflammatory conditions. This reflects its broader role as a marker of systemic neutrophil activation and innate immune activity.

Inflammatory Bowel Disease (Crohn’s and Ulcerative Colitis)

This is the primary clinical application of fecal calprotectin. In IBD, calprotectin correlates closely with endoscopic activity — meaning that as the gut lining becomes more inflamed under a camera, calprotectin rises proportionally. This makes it an invaluable tool for monitoring treatment response without repeated colonoscopies.

Irritable Bowel Syndrome (IBS)

Perhaps the most clinically useful aspect of calprotectin testing is its ability to distinguish IBD from IBS — two conditions with overlapping symptoms (abdominal pain, altered bowel habit, bloating) but fundamentally different pathologies. A meta-analysis of 17 studies involving nearly 2,000 patients demonstrated a summary sensitivity of 85.8% and specificity of 91.7% for calprotectin in distinguishing IBD from IBS. A low calprotectin level in a symptomatic patient substantially reduces the probability of IBD and supports a diagnosis of IBS — potentially sparing the patient an unnecessary colonoscopy.

Microscopic Colitis

This inflammatory condition — which only reveals itself on biopsy, not on standard endoscopic inspection — is associated with elevated calprotectin, although levels tend to be lower than in classical IBD. It is an important condition to consider in patients with chronic watery diarrhoea and a calprotectin in the borderline-to-elevated range.

Ankylosing Spondylitis and Inflammatory Arthritis

Research has shown that patients with ankylosing spondylitis have a distinctly altered gut microbiota composition associated with increased fecal calprotectin. This reflects the well-established connection between gut inflammation and inflammatory arthritis — the gut-joint axis — and highlights that gut inflammation can be subclinical in these patients while still driving systemic disease.

Calprotectin: IBD vs. IBS — A Critical Distinction

One of the most transformative applications of fecal calprotectin in clinical practice is helping to differentiate inflammatory bowel disease from irritable bowel syndrome. This distinction matters enormously — for treatment approach, prognosis, and patient quality of life.

IBD involves genuine structural damage to the intestinal mucosa, driven by an aberrant immune response. IBS, by contrast, is a functional gut disorder — bowel habits are disrupted by altered gut-brain signalling, visceral hypersensitivity, and motility dysfunction, but the gut lining itself is structurally normal. The symptoms of the two conditions can be virtually indistinguishable on clinical history alone.

A normal calprotectin result (under 50 µg/g) in a patient with classic IBS-type symptoms has an exceptionally high negative predictive value for IBD. At a prevalence of IBD of 1% in the general population, the negative predictive value of a normal calprotectin exceeds 99.8%. This has enormous implications for reducing unnecessary colonoscopies and healthcare costs, while reassuring patients appropriately.

What this means for you: If you’ve been experiencing gut symptoms and your calprotectin test comes back below 50 µg/g, this is genuinely reassuring. It strongly suggests that active mucosal inflammation — as seen in Crohn’s or colitis — is not the cause of your symptoms, and investigation should be directed towards functional gut disorders, dietary intolerances, or gut-brain axis dysfunction.

8 Clinically Researched Ways to Lower Calprotectin Naturally

The strategies below are not anecdotal — each is supported by peer-reviewed research indexed on PubMed. That said, these strategies are complementary to, not a replacement for, any prescribed medical treatment. Always work with your gastroenterologist or GP before making changes to your management plan.

Strategy 1: Curcumin Combined with Piperine for Enhanced Absorption

Curcumin — the active polyphenol from the turmeric root (Curcuma longa) — is one of the most extensively studied natural anti-inflammatory compounds in gastroenterology. A 2024 randomised, double-blind, placebo-controlled clinical trial published in Pharmaceuticals found that 12 weeks of curcumin supplementation (1,000 mg/day) combined with piperine (10 mg/day) significantly increased superoxide dismutase (SOD) levels — a critical antioxidant enzyme — compared to placebo in IBD patients. SOD is the body’s principal defence against reactive oxygen species (ROS), the unstable molecules that drive oxidative damage and amplify intestinal inflammation.

The inclusion of piperine — an alkaloid from black pepper — is crucial. Piperine inhibits hepatic glucuronidation, a metabolic process that would otherwise rapidly break down curcumin before it can act. Research has shown that piperine increases curcumin’s bioavailability by up to 2,000%. Without it, most oral curcumin supplements pass through the body largely unabsorbed. This combination therapy represents one of the most evidence-supported natural anti-inflammatory strategies available for individuals with gut inflammation. The trial authors noted the approach presents “therapeutic alternatives with minimal adverse effects.”

Practical application: Look for a supplement combining curcumin with piperine (sometimes labelled as bioperine). Taking it with a meal containing healthy fats further improves absorption. Aim for 500–1,000 mg curcumin alongside 5–10 mg piperine daily. Turmeric in cooking is beneficial, but the amounts achievable through food alone are unlikely to reach therapeutic doses.

Recommended Product: Curcumin 500

Evidence: RCT — Martins et al., Pharmaceuticals, 2024 (PubMed PMID: doi:10.3390/ph17070849)

Strategy 2: High-Dose Vitamin D Supplementation

Vitamin D deficiency is exceptionally prevalent in IBD patients, and the relationship is bidirectional — low vitamin D worsens disease activity, and active disease impairs vitamin D absorption. A landmark follow-up study published in Nutrients examined 40 Crohn’s disease patients who had received either seven weeks of high-dose vitamin D (a 200,000 IU bolus followed by 20,000 IU/day) or placebo. The findings were striking: the vitamin D group had 3.8 times lower fecal calprotectin at weeks 15 and 23 of follow-up compared to those who received placebo, with median calprotectin levels below 70 mg/kg in the vitamin D group versus above 250 mg/kg in the placebo group.

Furthermore, patients who had received vitamin D had significantly reduced need for infliximab dose-escalation over 45 weeks — a clinically meaningful finding suggesting that optimising vitamin D may help maintain the effectiveness of biological therapies. The anti-inflammatory effects are believed to operate via multiple mechanisms, including reduction of mucosal IL-17A and IFN-γ expression, enhancement of mucosal barrier function, and modulation of gut microbiome composition. Critically, high-dose vitamin D treatment remained safe throughout follow-up, with no patients experiencing hypercalcaemia.

Practical application: Have your serum 25-hydroxyvitamin D level checked. The optimal range for IBD patients appears to be above 75 nmol/L (30 ng/mL). Standard UK supplementation guidance (400–800 IU/day) is likely insufficient to achieve therapeutic levels — discuss higher-dose supplementation with your doctor.

Recommended Product: Vitamin D3 & K2

Evidence: Follow-Up RCT — Bendix et al., Nutrients, 2021 (PubMed doi:10.3390/nu13041083)

Strategy 3: The Mediterranean Diet Pattern

The Mediterranean diet — characterised by abundant vegetables, fruits, legumes, whole grains, olive oil, nuts, and moderate fish — is arguably the most well-evidenced anti-inflammatory dietary pattern available. A study published in Gut Microbes found that increasing adherence to the Mediterranean diet was associated with a statistically significant reduction in fecal calprotectin, alongside beneficial alterations in gut microbial composition. Butyrate-producing bacteria — including Faecalibacterium prausnitzii and Lachnospira species — were positively correlated with both Mediterranean diet adherence and daily step count.

The mechanism is multifactorial: the Mediterranean diet is rich in dietary fibre (which feeds beneficial gut bacteria and promotes short-chain fatty acid production), polyphenols (which have direct anti-inflammatory effects on the gut epithelium), omega-3 fatty acids (which antagonise pro-inflammatory eicosanoid synthesis), and extra virgin olive oil (which contains oleocanthal, a natural COX inhibitor). Each of these components exerts independent anti-inflammatory effects on the gut mucosa.

Practical application: Prioritise plant diversity — aim for at least 30 different plant foods per week, which research has linked to greater gut microbiome diversity. Use extra virgin olive oil as your primary cooking fat. Include oily fish (salmon, mackerel, sardines) at least 2–3 times per week. Reduce ultra-processed foods, refined carbohydrates, and red and processed meat.

Evidence: Clinical Study — Gut Microbes, 2022 (PubMed)

Strategy 4: Omega-3 Fatty Acids (Eicosapentaenoic Acid)

Eicosapentaenoic acid (EPA) — the primary omega-3 fatty acid found in oily fish and high-quality fish oil supplements — has a well-documented ability to modulate gut inflammation through its effects on eicosanoid metabolism. EPA competes with arachidonic acid for the same enzymatic pathways, displacing the production of highly inflammatory prostaglandins (PGE₂) and leukotrienes (LTB₄) in favour of their far less inflammatory omega-3 counterparts. Clinical studies have shown that EPA supplementation can reduce fecal calprotectin levels in patients with ulcerative colitis in remission, as well as reducing relapse rates.

A study by Scaioli and colleagues demonstrated that EPA supplementation in UC patients in remission both reduced calprotectin and extended time to relapse — a clinically meaningful outcome. The anti-inflammatory effects appear most pronounced when EPA replaces a diet already high in omega-6 fatty acids (found in vegetable oils, processed foods, and factory-farmed meat), since it is the ratio of omega-6 to omega-3 that governs the inflammatory tone of the intestinal mucosa.

Practical application: Aim for 2–3 portions of oily fish per week (salmon, mackerel, herring, sardines, anchovies). For supplementation, look for a high-quality fish oil or algal oil (suitable for vegetarians and vegans) providing at least 1,000 mg of combined EPA and DHA daily. Store in the fridge to prevent oxidation.

Recommended Product: Life & Soul

Evidence: Multiple PubMed-indexed clinical studies, including Scaioli et al., Clin Gastroenterol Hepatol, 2018

Strategy 5: Polyphenol-Rich Foods — Pomegranate, Berries, and Olive Oil

Dietary polyphenols are plant compounds with potent anti-inflammatory properties, many of which exert their effects directly at the level of the gut mucosa — where they reach much higher concentrations than most systemic drugs. A randomised controlled trial protocol published in Trials (Scaioli et al., 2019) investigated pomegranate juice (125 mL twice daily for 12 weeks) as a strategy to reduce fecal calprotectin in IBD patients at high risk of relapse. Pomegranate is a particularly rich source of ellagitannins (ETs) — large polyphenols that are metabolised by gut bacteria into urolithins, bioactive compounds that reach high concentrations in the colon and exert significant local anti-inflammatory effects.

Research shows that urolithins inhibit key pro-inflammatory signalling pathways including NF-κB, c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinase (ERK) — the same pathways implicated in IBD pathogenesis. A randomised controlled trial (the MaPLE trial, published in BMC Geriatrics, 2024) found that eight weeks on a polyphenol-rich diet produced statistically significant reductions in both fecal and serum calprotectin in older adults with increased intestinal permeability. Bilberry supplementation specifically has been shown to reduce calprotectin by up to 61% in patients with active ulcerative colitis.

Practical application: Focus on variety and consistency rather than any single superfood. Daily berries (blueberries, raspberries, strawberries), pomegranate seeds or juice, extra virgin olive oil, green tea, dark chocolate (over 85% cocoa), colourful vegetables, and walnuts together build a polyphenol-rich dietary profile that consistently supports mucosal anti-inflammatory activity.

Recommended Product: Poly-Pro Flora

Evidence: RCT Protocol — Scaioli et al., Trials, 2019 (PubMed PMID: 31171016); MaPLE Trial, BMC Geriatrics, 2024

Strategy 6: Targeted Probiotic and Prebiotic Supplementation

The gut microbiome is not merely a passive resident of the intestine — it actively participates in regulating mucosal immune function, maintaining the integrity of the gut barrier, and calibrating the inflammatory response. An imbalanced microbiome (dysbiosis) can sustain and amplify intestinal inflammation, perpetuating elevated calprotectin. Targeted probiotic supplementation aims to restore beneficial bacterial populations and dampen this inflammatory drive.

Clinical evidence supports the use of specific probiotic strains. A randomised trial found that probiotic administration significantly decreased calprotectin concentrations compared to placebo. Lactobacillus and Bifidobacterium species have been shown in multiple studies to modulate gut immune function through the stimulation of regulatory T cells, reduction of intestinal permeability, and competitive exclusion of pathogenic bacteria.

Prebiotic fibres — which selectively feed beneficial bacteria — further enhance this effect. Oligofructose-enriched inulin supplementation has been specifically associated with lowered fecal calprotectin in patients with acute ulcerative colitis (Casellas et al., Alimentary Pharmacology and Therapeutics). Inulin-rich foods include chicory root, Jerusalem artichoke, garlic, leeks, asparagus, and slightly unripe bananas.

Practical application: Rather than reaching for a generic probiotic, seek guidance on strain-specific products aligned with your condition. For gut inflammation, multi-strain products containing L. acidophilus, L. rhamnosus, and Bifidobacterium longum have the most evidence. Include prebiotic-rich foods daily. Fermented foods — kefir, live-culture yogurt, sauerkraut, kimchi, and miso — provide both probiotics and prebiotics naturally.

Recommended Product: Essential Biotic

Evidence: Multiple PubMed-indexed RCTs; Casellas et al., Aliment Pharmacol Ther, 2007

Strategy 7: Stress Reduction and the Gut-Brain Axis

The connection between psychological stress and gut inflammation is not metaphorical — it is biological and bidirectional. The gut-brain axis comprises neural, hormonal, and immune pathways that connect the central nervous system directly to the intestinal immune environment. Chronic psychological stress activates the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system, releasing cortisol and catecholamines that modulate intestinal permeability, alter microbiome composition, and shift the gut immune response towards a pro-inflammatory phenotype.

In practical terms, this means that emotional and psychological stress can genuinely worsen gut inflammation and elevate calprotectin levels — and conversely, effective stress management can be an authentic therapeutic intervention for gut health. Mind-body practices including mindfulness-based stress reduction (MBSR), cognitive behavioural therapy (CBT), yoga, and diaphragmatic breathing exercises have all been shown in PubMed-indexed studies to reduce inflammatory markers and improve quality of life in IBD patients. Sleep deprivation compounds this effect further, since gut epithelial repair is substantially impaired by poor sleep, and cytokine profiles shift towards inflammation with sleep restriction.

Practical application: Prioritise sleep hygiene (7–9 hours, consistent bed and wake times). Practise 10–15 minutes of diaphragmatic breathing or mindfulness daily. Consider working with a therapist trained in gut-directed hypnotherapy or CBT, both of which have clinical evidence in IBD. Reduce excessive high-intensity exercise during flares, as this transiently elevates gut permeability.

Evidence: Multiple PubMed gut-brain axis and IBD quality-of-life studies

Strategy 8: Identifying and Removing Dietary Triggers

While no universal “IBD diet” exists, the identification and elimination of individual dietary triggers can meaningfully reduce mucosal inflammation and calprotectin levels in susceptible individuals. Common culprits include ultra-processed foods (which contain emulsifiers like carboxymethylcellulose and polysorbate-80 that disrupt the intestinal mucus layer), artificial sweeteners (particularly sucralose and saccharin, which alter microbiome composition), excessive refined sugar and saturated fat (which drive pro-inflammatory cytokine expression), and gluten in individuals with coeliac disease or non-coeliac gluten sensitivity — where a strict gluten-free diet has been shown to normalise elevated calprotectin.

Red and processed meat is associated with increased intestinal inflammation in observational studies, likely due to its promotion of secondary bile acids and hydrogen sulfide-producing bacteria. A diet emphasising whole, minimally processed foods with high fibre diversity consistently outperforms restrictive elimination approaches in the long term. The Specific Carbohydrate Diet (SCD) and Mediterranean diet have both been studied in randomised trials in Crohn’s disease, with the Mediterranean diet performing comparably while being significantly easier to sustain long-term.

Practical application: Keep a detailed food-symptom diary for 4–6 weeks to identify personal triggers. Work with a FODMAP-trained dietitian if functional symptoms coexist. Do not embark on highly restrictive elimination diets without professional guidance, as nutritional deficiencies are common in IBD and excessive restriction can worsen them.

Evidence: Multiple dietary RCTs indexed on PubMed; Lewis et al., Inflamm Bowel Dis, 2017

Frequently Asked Questions

How quickly can calprotectin levels drop with treatment or lifestyle changes?

This varies depending on the underlying cause and severity of inflammation. In IBD patients starting effective biological therapy, calprotectin can fall within 4–8 weeks. With dietary interventions, meaningful reductions typically require 8–12 weeks of consistent adherence. The Mediterranean diet research showed measurable changes within 4 weeks; the vitamin D research demonstrated sustained reductions at 15 and 23 weeks. Serial testing every 6–12 weeks is typically sufficient to track progress.

Can I have a high calprotectin but feel completely well?

Yes — and this is clinically very important. In IBD, there is a well-recognised disconnect between clinical symptoms and mucosal inflammatory activity. A patient can feel relatively well while their gut lining is still actively inflamed — what is sometimes called “subclinical inflammation.” This is particularly common in ulcerative colitis. An elevated calprotectin in someone who feels well should not be dismissed; it predicts a significantly higher probability of relapse in the coming months and often warrants treatment escalation or closer monitoring.

Can ibuprofen or other NSAIDs affect my calprotectin test?

Yes, significantly. NSAIDs — ibuprofen, naproxen, diclofenac, and higher-dose aspirin — can damage the intestinal mucosa and elevate calprotectin even in healthy individuals. If you take NSAIDs regularly, disclose this to your doctor before testing. It may be advisable to hold NSAIDs for several weeks before a planned calprotectin test to obtain an accurate baseline reading.

Is stress really enough to raise calprotectin levels?

Acute psychological stress alone is unlikely to elevate calprotectin into the ranges seen in active IBD. However, chronic stress can sustain low-grade mucosal immune activation that maintains borderline-to-mildly elevated calprotectin. In established IBD, psychological stress is a documented trigger for flares — which drive substantially higher calprotectin levels. The gut-brain axis is real and measurable. Stress management is a legitimate component of gut health optimisation.

Is calprotectin the same as CRP?

No. C-reactive protein (CRP) is a blood marker produced by the liver in response to systemic inflammation — it reflects whole-body inflammatory activity. Fecal calprotectin is a stool marker that reflects local intestinal mucosal inflammation specifically. Calprotectin is considerably more sensitive than CRP for detecting intestinal inflammation; it is possible to have active mucosal IBD with a normal CRP but a markedly elevated calprotectin. The two tests complement each other and are often used together.

Can I use a home calprotectin test?

Home fecal calprotectin tests are commercially available and increasingly accurate. However, for clinical decision-making — including decisions about medication adjustments, endoscopy, or diagnosis — laboratory-grade ELISA testing ordered by a clinician remains the gold standard. Home tests are useful for general monitoring between appointments, but a positive result should always be followed up with your medical team.

When to See Your Doctor

While natural strategies play a genuine and evidence-supported role in reducing gut inflammation, certain scenarios require urgent or prompt medical attention. Do not rely solely on natural strategies in any of the following circumstances:

Calprotectin persistently above 250 µg/g: This consistently indicates significant mucosal inflammation and warrants clinical evaluation, even if you feel reasonably well. Your doctor may recommend endoscopy, medication adjustment, or investigation for an underlying cause.

Blood in your stool: Rectal bleeding alongside elevated calprotectin always requires prompt medical assessment to exclude colorectal cancer, active IBD flare, or other significant pathology. Do not delay seeking medical attention for this symptom.

Unintentional weight loss: Unexplained weight loss combined with elevated calprotectin is a red flag that warrants thorough gastroenterological investigation.

Fever with gut symptoms: Fever alongside diarrhoea and elevated calprotectin may indicate an infective gastroenteritis or serious IBD complication requiring medical management.

Nocturnal symptoms: Gut symptoms that consistently wake you from sleep are a red flag feature that distinguishes organic disease from functional disorders and requires medical evaluation.

The Bottom Line

Calprotectin is one of the most powerful non-invasive windows into gut health currently available. Understanding your levels, tracking them over time, and combining evidence-based natural strategies with appropriate medical care gives you the best possible foundation for reducing intestinal inflammation, maintaining remission, and protecting your long-term gut health.

The research is clear: diet, targeted supplementation, stress management, and microbiome support are not peripheral “nice-to-haves” — they are core pillars of gut health that meaningfully move the needle on calprotectin levels when applied consistently and thoughtfully. Curcumin combined with piperine, high-dose vitamin D, a Mediterranean dietary pattern, omega-3 fatty acids, polyphenol-rich foods, targeted probiotics, stress reduction, and the elimination of individual dietary triggers each have genuine, PubMed-indexed clinical evidence behind them. Used together and sustained over time, they represent a powerful natural adjunct to conventional IBD management.

References

1. Martins AS et al. Effect of Curcumin Plus Piperine on Redox Imbalance, Fecal Calprotectin and Cytokine Levels in Inflammatory Bowel Disease Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Pharmaceuticals. 2024;17(7):849. doi:10.3390/ph17070849
2. Bendix M et al. Seven Weeks of High-Dose Vitamin D Treatment Reduces the Need for Infliximab Dose-Escalation and Decreases Inflammatory Markers in Crohn’s Disease during One-Year Follow-Up. Nutrients. 2021;13(4):1083. doi:10.3390/nu13041083
3. Scaioli E et al. Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial. Trials. 2019;20:327. doi:10.1186/s13063-019-3321-8
4. Konikoff MR, Denson LA. Role of fecal calprotectin as a biomarker of intestinal inflammation in IBD. Inflamm Bowel Dis. 2006;12(6):524–34. PMID: 16775498
5. Elli L et al. Diagnostic performance of faecal calprotectin in distinguishing IBD from IBS in adults — systematic review with meta-analysis. Aliment Pharmacol Ther. 2023. doi:10.1111/apt.17754
6. Klingberg E et al. A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin. Arthritis Res Ther. 2019;21(1). doi:10.1186/s13075-019-2018-4
7. Scaioli E et al. Eicosapentaenoic acid reduces fecal levels of calprotectin and prevents relapse in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2018;16:1268–75. PMID: 29309929
8. Liguori G et al. A (poly)phenol-rich diet reduces serum and faecal calprotectin in older adults with increased intestinal permeability: the MaPLE randomised controlled trial. BMC Geriatrics. 2024. doi:10.1186/s12877-024-05272-y
9. Parra-Izquierdo I et al. Increasing adherence to the Mediterranean diet is associated with reduced fecal calprotectin. Gut Microbes. 2022. doi:10.1080/19490976.2022.2120749
10. Lewis JD et al. The importance and challenges of dietary intervention trials for inflammatory bowel disease. Inflamm Bowel Dis. 2017;23:181–91. PMID: 27997415
11. Casellas F et al. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered fecal calprotectin. Aliment Pharmacol Ther. 2007;25(9):1061–7. PMID: 17439509
12. Charbit-Henrion F et al. Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases. Am J Gastroenterol. 2023. PMC10522095

---

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making changes to your diet, supplement regimen, or medical treatment plan.